This topic contains a solution. Click here to go to the answer

Author Question: In twin studies the key comparison involves determining how many pairs of twins either have the same ... (Read 106 times)

swpotter12

  • Hero Member
  • *****
  • Posts: 527
In twin studies the key comparison involves determining how many pairs of twins either have the same disorder or are free of the disorder; this involves the calculation of
 
  a. discordance rates.
  b. concordance rates.
  c. shared environment rates.
  d. nonshared environment rates.

Question 2

Similar concordance rates for a given trait in monozygotic (MZ) and dizygotic (DZ) twins suggests that the trait may be due to
 
  a. genetic causes.
  b. endocrine causes.
  c. environmental causes.
  d. phonotypical causes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

diana chang

  • Sr. Member
  • ****
  • Posts: 288
Answer to Question 1

Answer: b.

Answer to Question 2

Answer: c.




swpotter12

  • Member
  • Posts: 527
Reply 2 on: Jun 22, 2018
Excellent


ktidd

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

In the ancient and medieval periods, dysentery killed about ? of all babies before they reach 12 months of age. The disease was transferred through contaminated drinking water, because there was no way to adequately dispose of sewage, which contaminated the water.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library